catalent glp-1 x Novo: and Antitrust Concerns as Industry Reacts to the $16.5B Acquisition OptiForm® Solution Suite - Catalent

DduB2B

Manufactured in a cGMP-certified facility.

#lemmeglp1 #lemme #kourtneykardashian #supplements #ozempic #ozempicweightloss #naturesozempic #glp1...

GLP-1 drugs are making waves in the world of weight loss and health management, but what exactly are they

What they found was cost dominates treatment decisions: 68% said cost influenced their decision to start or continue treatment 44% said the medication cost more than they expected Cost surpassed side effects as the #1 reason people stopped taking GLP-1s A breakdown of the financial burden: 24% pay more than $250 per prescription fill Nearly 8% pay $500 or more per fill 24% said insurance didn't cover any cost Weight management patients were nearly twice as likely to pay $250+ vs diabetes patients --- Here's what patients are thinking: Nearly 40% ended up using discount programs or manufacturer coupons 60% know someone who wants GLP-1s but can't afford them 83% believe Americans turn to DTC programs because traditional healthcare is too expensive Patients still prioritize safety: 60% are aware of safety risks with non-FDA-approved GLP-1s--this one surprised me

People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their odds for a dangerous blood clot, new research finds.